News

There have been many milestones in Crimson's journey so far and every passing day adds something new. To know more about the happenings at Crimson, check out this section.

Select Year:

Ulatus Launches Life Science Localization Solution

August 2017
Health sector can now expand their reach with the localization support from Ulatus

August 31, 2017, New York: Ulatus, one of the leading language solutions providers worldwide, announced the launch of its Life Science Localization solution to help the heavily regulated life science industry. These solutions cater to Pharmaceutical, Biotech, Medical Device companies and CROs to help them venture into newer markets. Companies like Pfizer, Novartis, Takeda, Sanofi and Abbot have achieved faster approval for their health products because of these solutions. Having had substantial experience in the translation industry, it was a natural move for Ulatus to extend its offerings to the medical industry with its localization services. Ulatus aims to simplify globalization, allowing medical companies to reach new markets, while adhering to international regulatory standards.

The solutions cover significant aspects of life science localization by offering translations for clinical trials, regulatory submissions, and medical devices. Additionally, an ISPOR compliant comprehensive linguistic validation service ensures that the Clinical outcome assessments (COAs) are equivalent with the original and relevant to the target culture. As a result, pharma companies can target foreign markets in which they want to conduct trials or launch their drugs. To ensure regulatory compliance, Ulatus has a team of life science specialists with expertise in working with local and international regulatory agencies.

“We are pleased to offer our life science localization service for such a critically regulated industry,” said Shilpa Mittal, CEO, Ulatus. “At Ulatus, we understand the legal and cultural challenges involved in translating documents for this industry, which is why we have 0 error tolerance limit. Our life science experts have worked extensively with international regulatory agencies like FDA, EMA, CFDA and PMDA, and we make sure that our translation meets those requirements.”

A non-localized and inaccurate translation can do major harm to a company when going global. Ulatus ensures that all documentation is linguistically accurate and culturally appropriate. Strictly following the regulator’s strict guidelines, Ulatus delivers translated terminologies and concepts which are valid and appropriate for the target market. While working with companies to overcome regional barriers, Ulatus provides precise translation of protocols, IBs, ICFs, CRFs, PROs, Adverse Event reports, and many other document types.

About Ulatus

Ulatus is one of the world’s leading translation service providers. With a pool of 1200+ expert translators, Ulatus provides professional translation services to more than 140,000 clients from over 125 countries. The translation accuracy, superior quality, advanced linguistic capability, and expertise in language nuances is what differentiates Ulatus.

To learn more about Ulatus, please visit: ulatus.com





Let's Work Together